ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN PATIENTS WITH COLORECTAL CANCER?
Fabiola Pabst BremerNicolau Gregori CzeczkoLuis Martins CollaçoLetícia Elizabeth Augustin Czeczko RutzGuilherme GionedisCamila Kienen YamakawaPublished in: Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery (2020)
CDX2, beta-catenin and Wnt3a are not useful to predict prognosis in patients with CRC.